J&J | JNJ - Operating Expenses

Stock Price
234.35
Daily Change
1.25 0.54%
Monthly
14.70%
Yearly
51.50%
Q1 Forecast
220.25

J&J reported $18.97B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AbbVie USD -2.64B 12.35B Sep/2025
Abbott USD 9.21B 17M Dec/2025
Amgen USD 5.9B 773M Dec/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Boston Scientific USD 4.03B 94M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
CONMED USD 336.58M 10.53M Dec/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dexcom USD 966.8M 22.3M Sep/2025
Edwards Lifesciences USD 1.13B 26.7M Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Gilead Sciences USD 4.26B 95M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Insulet USD 588.6M 60.6M Sep/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.26B 283M Sep/2025
Merck USD 10.16B 558M Dec/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 272.12M 421K Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
Vertex Pharmaceuticals USD 1.84B 27.1M Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025
Zoetis USD 5.4B 3.94B Sep/2025